Vivos (RDGL) Depreciation & Amortization (CF) (2010 - 2017)
Vivos recorded quarterly Depreciation & Amortization (CF) of $733.0 in Q2 2017, down 0.95% quarter-over-quarter from $740.0 in Q1 2017, and down 0.54% year-over-year from $737.0 in Q2 2016.
Vivos' Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $733.0 for Q2 2017.
- In Q2 2017, Depreciation & Amortization (CF) fell 0.54% year-over-year to $733.0; the TTM figure through Mar 2018 stood at $733.0 (down 75.14% YoY), while the FY2025 annual figure was $374.0, changed N/A from the prior year.
- Depreciation & Amortization (CF) came in at $733.0 for Q2 2017 at Vivos, down from $740.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $112947.0 in Q1 2013 to a low of $733.0 in Q2 2017.
- A 5-year average of $11925.3 and a median of $1329.5 in 2015 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) sank 98.64% in 2014 and increased 0.27% in 2017, its largest moves.
- Vivos' Depreciation & Amortization (CF) stood at $1540.0 in 2013, then changed by 0.0% to $1540.0 in 2014, then slumped by 52.08% to $738.0 in 2015, then decreased by 0.54% to $734.0 in 2016, then retreated by 0.14% to $733.0 in 2017.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $733.0, $740.0, and $734.0 for Q2 2017, Q1 2017, and Q4 2016 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Vivos | - | - | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 733.00 |
| Jun 30, 2017 | 733.00 |
| Mar 31, 2017 | 740.00 |
| Mar 31, 2017 | 740.00 |
| Dec 31, 2016 | 734.00 |
| Dec 31, 2016 | 734.00 |
| Sep 30, 2016 | 738.00 |
| Sep 30, 2016 | 738.00 |
| Jun 30, 2016 | 737.00 |
| Jun 30, 2016 | 737.00 |
| Mar 31, 2016 | 738.00 |
| Mar 31, 2016 | 738.00 |
| Dec 31, 2015 | 738.00 |
| Dec 31, 2015 | 738.00 |
| Sep 30, 2015 | 936.00 |
| Sep 30, 2015 | 936.00 |
| Jun 30, 2015 | 1,329.00 |
| Jun 30, 2015 | 1,329.00 |
| Mar 31, 2015 | 1,330.00 |
| Mar 31, 2015 | 1,330.00 |
| Dec 31, 2014 | 1,540.00 |
| Dec 31, 2014 | 1,540.00 |
| Sep 30, 2014 | 1,540.00 |
| Sep 30, 2014 | 1,540.00 |
| Jun 30, 2014 | 1,540.00 |
| Jun 30, 2014 | 1,540.00 |
| Mar 31, 2014 | 1,540.00 |
| Mar 31, 2014 | 1,540.00 |
| Dec 31, 2013 | 1,540.00 |
| Dec 31, 2013 | 1,540.00 |
| Sep 30, 2013 | 1,803.00 |
| Sep 30, 2013 | 1,803.00 |
| Jun 30, 2013 | 83,453.00 |
| Jun 30, 2013 | 83,453.00 |
| Mar 31, 2013 | 112,947.00 |
| Mar 31, 2013 | 112,947.00 |
| Dec 31, 2012 | 98,328.00 |
| Dec 31, 2012 | 98,328.00 |
| Sep 30, 2012 | 98,330.00 |
| Sep 30, 2012 | 98,330.00 |
| Jun 30, 2012 | 137,690.00 |
| Jun 30, 2012 | 137,690.00 |
| Mar 31, 2012 | 137,690.00 |
| Mar 31, 2012 | 137,690.00 |
| Dec 31, 2011 | 134,930.00 |
| Dec 31, 2011 | 134,930.00 |
| Sep 30, 2011 | 134,930.00 |
| Sep 30, 2011 | 134,930.00 |
| Jun 30, 2011 | 134,930.00 |
| Jun 30, 2011 | 134,930.00 |
| Mar 31, 2011 | 134,930.00 |
| Mar 31, 2011 | 134,930.00 |
| Dec 31, 2010 | 135,195.00 |
| Dec 31, 2010 | 135,195.00 |
| Sep 30, 2010 | 135,048.00 |
| Sep 30, 2010 | 135,048.00 |